Design and application of new fluoroescent substrate against membrane-bound processing enzyme

新型膜结合酶荧光底物的设计及应用

基本信息

  • 批准号:
    11557138
  • 负责人:
  • 金额:
    $ 8.45万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2001
  • 项目状态:
    已结题

项目摘要

RANKL (receptor activator of NF-KB ligand), an essential factor of osteoclastogenesis, exists as a membrane-bound and soluble form. Our aim was to identify its processing enzyme.First, to establish soluble RANKL expression system, ST2 cells, preosteoclast like cells, were treated by vitamine D3 (Vit D3) and dexamethasone (Dex). In general, RANKL is not produced in ST2 cells. But when ST2 cells were treated with Vit D3 and Dex, soluble form (MW ; about 30 kDa) was secreted into culture medium. Identification of soluble form was carried out by LRP (ligand-receptor precipitation) method. LRP is a new Western blot analysis that can specifically concentrate the target protein by using specific binding between RANKL and OPG (osteoprotegerin).Next, N-terminal ammo acid sequences of soluble RANKL were decided. The cleavage of membrane-bound to soluble form occurred between Arg (138) and Phe (139), and its cleavage was inhibited by KB8301, a metalloproteinase inhibitor. Currently, it is said that the candidate of processing enzyme is an ADAM family protein. Among them, mRNA expression of TACE (ADAM 17) and Kuzbanian (ADAM 10) were confirmed by RT-PCR.To examine the role of glycolipids in osteoclast formation, glycosylceramide synthase inhibitor (D-PDMP) was added to culture medium. Although the differentiation of preosteoclast to osteoclast was completely blocked by addition of D-PDMP, exogenous lactosylceramid (LacCer) significantly recovered the osteoclast formation and the phosphorylation of NF-kB and ERK inhibited by ^D PDMP. These results suggest that LacCer is important for the differentiation of osteoclast.
核因子-KB配体受体激活剂(RANKL)是破骨细胞生成的重要因子,以膜结合和可溶性形式存在。首先,为了建立可溶性RANKL表达系统,用维生素D3(VitD3)和地塞米松(Dex)处理破骨前细胞ST2细胞。一般来说,在ST2细胞中不产生RANKL。而用维生素D3和地塞米松处理ST2细胞后,可见约30 kDa的可溶性蛋白分泌到培养液中。采用LRP(配基-受体沉淀法)对可溶性蛋白进行鉴定。LRP是一种新的蛋白质印迹分析方法,它利用RANKL与骨保护素(OPG)的特异性结合来特异地浓缩目的蛋白。在Arg(138)和Phe(139)之间发生了膜结合到可溶性的切割,其切割被金属蛋白酶抑制剂KB8301抑制。目前认为加工酶的候选蛋白是一种亚当家族蛋白。其中TACE(ADAM 17)和Kuzbanian(ADAM 10)的mRNA表达经RT-PCR证实。为了检测糖脂在破骨细胞形成中的作用,在培养液中加入糖基神经酰胺合成酶抑制剂(D-PDMP)。D-PDMP可完全阻断破骨前细胞向破骨细胞的分化,但外源性乳糖神经酰胺(LacCer)可显著恢复破骨细胞的形成,并能显著恢复D-PDMP抑制的核因子-kB和ERK的磷酸化。这些结果提示LacCer对破骨细胞的分化具有重要作用。

项目成果

期刊论文数量(57)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Iwamoto T., et al.: "Lactosylceramide is essential for the osteoclastgenesis mediated by macrophage colony-stimulating factor and receptor activator of nuclear factor-kB ligan"J.Biol.Chem.. 276. 46031-46038 (2001)
Iwamoto T.等人:“乳糖神经酰胺对于巨噬细胞集落刺激因子和核因子-kB配体受体激活剂介导的破骨细胞生成至关重要”J.Biol.Chem.. 276. 46031-46038 (2001)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yasuda Y., Ikeda S., Sakai H., Tsukuba T., Okamoto K., Nishikawa K. Akamine A., Kato Y., and Yamamoto K.: "role of N-glycosylation in cathepsin E"Eur. J. Biochem. 266. 381-91 (1999)
Yasuda Y.、Ikeda S.、Sakai H.、Tsukuba T.、Okamoto K.、Nishikawa K. Akamine A.、Kato Y. 和 Yamamoto K.:“N-糖基化在组织蛋白酶 E 中的作用”Eur。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hashimoto F., et al.: "Expression and localization of MGP in rat cementum"Archives of Oral Biology. 46. 585-592 (2001)
Hashimoto F. 等人:“MGP 在大鼠牙骨质中的表达和定位”口腔生物学档案。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hashimoto F., Kobayashi Y., Kobayashi E.T., Sakai E., Kobayashi K., Kato Y., and Sakai H.: "Expression and localization of MGP in rat tooth cementum"Arch. Oral Biol.. 46(7). 585-592 (2000)
Hashimoto F.、Kobayashi Y.、Kobayashi E.T.、Sakai E.、Kobayashi K.、Kato Y. 和 Sakai H.:“MGP 在大鼠牙骨质中的表达和定位”Arch。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Iwamoto T., et al.: "Lactosylceramide is essential for the osteoclastgenesis mediated by macrophage colony-stimulating factor and receptor activator of nuclear factor-kB ligan"Journal of Biological Chemistry. 276. 46031-46038 (2001)
Iwamoto T.等人:“乳糖神经酰胺对于巨噬细胞集落刺激因子和核因子-kB配体受体激活剂介导的破骨细胞生成至关重要”生物化学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KATO Yuzo其他文献

KATO Yuzo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KATO Yuzo', 18)}}的其他基金

On the custom of real estimate's transaction in the concessions and the settlements of modern China
论近代中国租界和聚落中的实价交易习惯
  • 批准号:
    20730010
  • 财政年份:
    2008
  • 资助金额:
    $ 8.45万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Study of the correlation bone in osteoclast resorption with atopic disease
破骨细胞吸收与特应性疾病相关性骨的研究
  • 批准号:
    15390563
  • 财政年份:
    2003
  • 资助金额:
    $ 8.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Roles of metalloprotease-disintegrins in osteoclastogenesis
金属蛋白酶解整合素在破骨细胞生成中的作用
  • 批准号:
    09470404
  • 财政年份:
    1997
  • 资助金额:
    $ 8.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Role of osteocalcin in the calcium metabolism disorder
骨钙素在钙代谢紊乱中的作用
  • 批准号:
    05454505
  • 财政年份:
    1993
  • 资助金额:
    $ 8.45万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Roles of lysosomal proteinases in the patho-physiological changes of hard tissues.
溶酶体蛋白酶在硬组织病理生理变化中的作用。
  • 批准号:
    62480381
  • 财政年份:
    1987
  • 资助金额:
    $ 8.45万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Investigation of the effect of soluble dietary fiber on glycolipid metabolism via gut metabolites
通过肠道代谢物研究可溶性膳食纤维对糖脂代谢的影响
  • 批准号:
    23K13909
  • 财政年份:
    2023
  • 资助金额:
    $ 8.45万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Chemical Tools to Elucidate Glycolipid Biosynthesis and Transport in the Corynebacterineae
合作研究:阐明棒状杆菌亚科糖脂生物合成和运输的化学工具
  • 批准号:
    2303703
  • 财政年份:
    2023
  • 资助金额:
    $ 8.45万
  • 项目类别:
    Standard Grant
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
  • 批准号:
    10935775
  • 财政年份:
    2023
  • 资助金额:
    $ 8.45万
  • 项目类别:
Glycolipid biointerface to decipher disease-implicated ganglioside-protein interactions
糖脂生物界面破译疾病相关神经节苷脂-蛋白质相互作用
  • 批准号:
    10737003
  • 财政年份:
    2023
  • 资助金额:
    $ 8.45万
  • 项目类别:
Collaborative Research: Chemical Tools to Elucidate Glycolipid Biosynthesis and Transport in the Corynebacterineae
合作研究:阐明棒状杆菌亚科糖脂生物合成和运输的化学工具
  • 批准号:
    2303704
  • 财政年份:
    2023
  • 资助金额:
    $ 8.45万
  • 项目类别:
    Standard Grant
Elucidation of reaction machinery for novel bacterial glycolipid synthases and their applications
新型细菌糖脂合酶反应机制的阐明及其应用
  • 批准号:
    22H02261
  • 财政年份:
    2022
  • 资助金额:
    $ 8.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of Novel Cartilage Regeneration Materials with Functional Glycolipid Molecules
功能性糖脂分子新型软骨再生材料的开发
  • 批准号:
    22H03917
  • 财政年份:
    2022
  • 资助金额:
    $ 8.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Structure and function of glycolipid MPIase involved in biogenesis of membrane proteins
参与膜蛋白生物合成的糖脂 MPIase 的结构和功能
  • 批准号:
    22H02567
  • 财政年份:
    2022
  • 资助金额:
    $ 8.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Developing enhanced production and separation techniques for glycolipid biosurfactants
开发糖脂生物表面活性剂的强化生产和分离技术
  • 批准号:
    2442425
  • 财政年份:
    2020
  • 资助金额:
    $ 8.45万
  • 项目类别:
    Studentship
Analysis of antibodies to glycolipid-protein complexes and elucidation of pathology in autoimmune-mediated demyelinating neuropathies
糖脂-蛋白质复合物的抗体分析和自身免疫介导的脱髓鞘性神经病的病理学阐明
  • 批准号:
    20K07894
  • 财政年份:
    2020
  • 资助金额:
    $ 8.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了